Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979591570> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1979591570 abstract "Survivin is a dual functioning protein. It inhibits the apoptosis of cells by inhibiting caspases, and also promotes cell growth by stabilizing microtubules during mitosis. Furthermore, over-expression of survivin has been shown to induce drug resistance to various chemotherapeutic compounds. Since the molecular chaperone Hsp90 binds and stabilizes survivin, it is widely believed that down-regulation of survivin is one of the important therapeutic functions of Hsp90 inhibitors such as the phase III clinically trialed compound 17-AAG. However, Hsp90 interferes with a number of molecules that positively regulate the intracellular level of survivin, raising the question that clinical use of Hsp90 inhibitors may indirectly induce survivin expression and subsequently promote cancer progression under certain circumstances. Here, we demonstrated that Hsp90 inhibitors, geldanamycin and 17-AAG, induced the over-expression of survivin in three different human cancer cell lines as shown by western blotting. Increased survivin mRNA transcripts were observed in 17-AAG and geldanamycin-treated HT-29 and HONE-1 cancer cells. Interestingly, real-time PCR and translation inhibition studies revealed that survivin was over-expressed partially through the up-regulation of protein translation instead of gene transcription in A549 cancer cells. In addition, 17-AAG-treated A549, HONE-1 and HT-29 cells showed reduced amount of 26S proteasome and decreased proteasomal activity while inhibition of 26S proteasome further increased the amount of survivin protein in cells. At the functional level, down-regulation of survivin by siRNA further increased the drug sensitivity to 17-AAG in the tested cancer cell lines. In conclusion, we showed for the first time that targeting Hsp90 induced the over-expression of survivin through various mechanisms in cancer cells. These data indicate that down-regulation of survivin is not a definite therapeutic function of Hsp90 inhibitors. The current study suggests that dual inhibition of Hsp90 and survivin may be warranted. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4447." @default.
- W1979591570 created "2016-06-24" @default.
- W1979591570 creator A5006222144 @default.
- W1979591570 creator A5011414516 @default.
- W1979591570 creator A5018673219 @default.
- W1979591570 creator A5023980054 @default.
- W1979591570 creator A5025107428 @default.
- W1979591570 creator A5088923237 @default.
- W1979591570 date "2010-04-15" @default.
- W1979591570 modified "2023-09-25" @default.
- W1979591570 title "Abstract 4447: Targeting Hsp90 with small molecule inhibitors induces the overexpression of the anti-apoptotic molecule, survivin, in human cancer cells" @default.
- W1979591570 doi "https://doi.org/10.1158/1538-7445.am10-4447" @default.
- W1979591570 hasPublicationYear "2010" @default.
- W1979591570 type Work @default.
- W1979591570 sameAs 1979591570 @default.
- W1979591570 citedByCount "0" @default.
- W1979591570 crossrefType "proceedings-article" @default.
- W1979591570 hasAuthorship W1979591570A5006222144 @default.
- W1979591570 hasAuthorship W1979591570A5011414516 @default.
- W1979591570 hasAuthorship W1979591570A5018673219 @default.
- W1979591570 hasAuthorship W1979591570A5023980054 @default.
- W1979591570 hasAuthorship W1979591570A5025107428 @default.
- W1979591570 hasAuthorship W1979591570A5088923237 @default.
- W1979591570 hasConcept C104317684 @default.
- W1979591570 hasConcept C121608353 @default.
- W1979591570 hasConcept C153911025 @default.
- W1979591570 hasConcept C185592680 @default.
- W1979591570 hasConcept C190283241 @default.
- W1979591570 hasConcept C205260736 @default.
- W1979591570 hasConcept C2775932338 @default.
- W1979591570 hasConcept C2775975398 @default.
- W1979591570 hasConcept C2777408456 @default.
- W1979591570 hasConcept C2780297055 @default.
- W1979591570 hasConcept C31573885 @default.
- W1979591570 hasConcept C502942594 @default.
- W1979591570 hasConcept C54355233 @default.
- W1979591570 hasConcept C55493867 @default.
- W1979591570 hasConcept C86803240 @default.
- W1979591570 hasConcept C95444343 @default.
- W1979591570 hasConcept C96232424 @default.
- W1979591570 hasConceptScore W1979591570C104317684 @default.
- W1979591570 hasConceptScore W1979591570C121608353 @default.
- W1979591570 hasConceptScore W1979591570C153911025 @default.
- W1979591570 hasConceptScore W1979591570C185592680 @default.
- W1979591570 hasConceptScore W1979591570C190283241 @default.
- W1979591570 hasConceptScore W1979591570C205260736 @default.
- W1979591570 hasConceptScore W1979591570C2775932338 @default.
- W1979591570 hasConceptScore W1979591570C2775975398 @default.
- W1979591570 hasConceptScore W1979591570C2777408456 @default.
- W1979591570 hasConceptScore W1979591570C2780297055 @default.
- W1979591570 hasConceptScore W1979591570C31573885 @default.
- W1979591570 hasConceptScore W1979591570C502942594 @default.
- W1979591570 hasConceptScore W1979591570C54355233 @default.
- W1979591570 hasConceptScore W1979591570C55493867 @default.
- W1979591570 hasConceptScore W1979591570C86803240 @default.
- W1979591570 hasConceptScore W1979591570C95444343 @default.
- W1979591570 hasConceptScore W1979591570C96232424 @default.
- W1979591570 hasLocation W19795915701 @default.
- W1979591570 hasOpenAccess W1979591570 @default.
- W1979591570 hasPrimaryLocation W19795915701 @default.
- W1979591570 hasRelatedWork W1892851123 @default.
- W1979591570 hasRelatedWork W1966494937 @default.
- W1979591570 hasRelatedWork W2018535512 @default.
- W1979591570 hasRelatedWork W2039046175 @default.
- W1979591570 hasRelatedWork W2045598393 @default.
- W1979591570 hasRelatedWork W2089686334 @default.
- W1979591570 hasRelatedWork W2143326507 @default.
- W1979591570 hasRelatedWork W2207869383 @default.
- W1979591570 hasRelatedWork W2257878018 @default.
- W1979591570 hasRelatedWork W2285204393 @default.
- W1979591570 hasRelatedWork W2324067070 @default.
- W1979591570 hasRelatedWork W2332060248 @default.
- W1979591570 hasRelatedWork W2339458708 @default.
- W1979591570 hasRelatedWork W2396545043 @default.
- W1979591570 hasRelatedWork W2532707259 @default.
- W1979591570 hasRelatedWork W2575982023 @default.
- W1979591570 hasRelatedWork W2803426430 @default.
- W1979591570 hasRelatedWork W2953154286 @default.
- W1979591570 hasRelatedWork W2998755991 @default.
- W1979591570 hasRelatedWork W2186531843 @default.
- W1979591570 isParatext "false" @default.
- W1979591570 isRetracted "false" @default.
- W1979591570 magId "1979591570" @default.
- W1979591570 workType "article" @default.